Home Cart Sign in  
Chemical Structure| 465-99-6 Chemical Structure| 465-99-6

Structure of Hederagenin
CAS No.: 465-99-6

Chemical Structure| 465-99-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Hederagenin is a plant metabolite which can prevent fungal growth, bacterial growth, and viral plant diseases.

Synonyms: Astrantiagenin E; Caulosapogenin; NSC 24954

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Hederagenin

CAS No. :465-99-6
Formula : C30H48O4
M.W : 472.70
SMILES Code : O=C(O)[C@]35[C@H](C\2=C\C[C@@H]1[C@@]4([C@@H](CC[C@]1([C@]/2(C)CC3)C)[C@](C)(CO)[C@@H](O)CC4)C)CC(C)(C)CC5
Synonyms :
Astrantiagenin E; Caulosapogenin; NSC 24954
MDL No. :MFCD00017385
InChI Key :PGOYMURMZNDHNS-MYPRUECHSA-N
Pubchem ID :73299

Safety of Hederagenin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MGC803 50 μM 24 h Hederagenin led to elevated LC3-II and p62 levels, indicating common autophagy inhibition in cancer cells derived from different tissues. Cell Death Dis. 2020 Aug 13;11(8):611
HepG2 50 μM 24 h Hederagenin led to elevated LC3-II and p62 levels, indicating common autophagy inhibition in cancer cells derived from different tissues. Cell Death Dis. 2020 Aug 13;11(8):611
CNE2 50 μM 24 h Hederagenin led to elevated LC3-II and p62 levels, indicating common autophagy inhibition in cancer cells derived from different tissues. Cell Death Dis. 2020 Aug 13;11(8):611
A375 50 μM 24 h Hederagenin led to elevated LC3-II and p62 levels, indicating common autophagy inhibition in cancer cells derived from different tissues. Cell Death Dis. 2020 Aug 13;11(8):611
NCI-H1975 50 μM 24 h To observe the effects of Hederagenin on autophagy in lung cancer cells, results showed that Hederagenin increased the number of autophagosomes and upregulated LC3-II and p62 expression, indicating impaired autophagic flux. Cell Death Dis. 2020 Aug 13;11(8):611
NCI-H1299 50 μM 24 h To observe the effects of Hederagenin on autophagy in lung cancer cells, results showed that Hederagenin increased the number of autophagosomes and upregulated LC3-II and p62 expression, indicating impaired autophagic flux. Cell Death Dis. 2020 Aug 13;11(8):611
A549 cells 50 µM 7 hours Evaluate the effect of Hederagenin on A549 cell viability, results showed significant reduction in cell viability at concentrations higher than 50 µM Int J Mol Sci. 2024 May 30;25(11):6026
RAW 264.7 cells 25 μg/mL 24 hours To evaluate the inhibitory effect of Hederagenin on NO generation, results showed that Hederagenin significantly inhibited NO generation without cytotoxicity. Nutrients. 2017 Jan 6;9(1):41
PC12 cells 0.3 µM 48 hours To evaluate the effect of Hederagenin on CORT-induced apoptosis. Results showed that Hederagenin significantly reduced CORT-induced apoptosis. Front Pharmacol. 2021 Oct 14;12:712876
PC12 cells 0.3 µM 48 hours To evaluate the effect of Hederagenin on CORT-induced increase in intracellular reactive oxygen species (ROS) levels. Results showed that Hederagenin inhibited the CORT-induced increase in ROS levels. Front Pharmacol. 2021 Oct 14;12:712876
PC12 cells 0.3 µM 48 hours To evaluate the protective effect of Hederagenin against CORT-induced mitochondrial membrane potential loss. Results showed that Hederagenin significantly attenuated the CORT-induced decline in mitochondrial membrane potential. Front Pharmacol. 2021 Oct 14;12:712876
PC12 cells 0.03, 0.1, 0.3, 1 µM 48 hours To evaluate the protective effect of Hederagenin against CORT-induced damage in PC12 cells. Results showed that Hederagenin protected PC12 cells against CORT-induced damage in a concentration-dependent manner. Front Pharmacol. 2021 Oct 14;12:712876
HEL cells 10, 20, 40, 80 µM 48 hours Inhibits HEL cell proliferation, downregulates FLI1 protein, upregulates MiR145 Int J Mol Sci. 2024 Dec 14;25(24):13426

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice NCI-H1299 lung cancer xenograft model Intraperitoneal injection 25 mg/kg Once daily for 11 days To evaluate the inhibitory effect of Hederagenin combined with cisplatin on tumor growth, results showed that the combination significantly inhibited tumor growth with a synergistic effect. Cell Death Dis. 2020 Aug 13;11(8):611
Wistar rats Alcohol-induced liver injury model Oral 50 mg/kg/day Once daily for 21 days To evaluate the protective effect of Hederagenin on alcohol-induced liver injury, results showed that Hederagenin significantly alleviated liver injury, inflammation, and apoptosis. Nutrients. 2017 Jan 6;9(1):41
C57BL/6J (B6) mice Middle cerebral artery occlusion (MCAO) model Intraperitoneal injection 26.5, 53, or 106 μmol/kg body weight Once daily for 3 consecutive days HE treatment attenuated CI/R-induced apoptosis and inflammatory cytokine expression within the infarcted areas and decreased the activation of the MLK3 signalling pathway. Front Pharmacol. 2020 Jul 30;11:1173

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.12mL

0.42mL

0.21mL

10.58mL

2.12mL

1.06mL

21.16mL

4.23mL

2.12mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories